Niagen Bioscience's major customers
AS Watson Group accounted for 13% of Niagen Bioscience's revenue in FY 2024, about the same as 15% a year earlier.
Get an email when Niagen Bioscience's customer concentration changes
When a new annual report adds a 10% customer, drops one, or moves a share by 5 points or more, you get the change and the filing link. Up to 10 companies per address, no account, unsubscribe with one click.
Major customers of Niagen Bioscience
Customers that Niagen Bioscience named in its annual report as 10% or more of revenue. A missing year means the customer was below that line or not named.
| Customer | Share of revenue | Change vs prior year | History | Latest filing |
|---|---|---|---|---|
| AS Watson Group | 13% | from 15% | 5 years | FY 2024 · filed 4 Mar 2026 |
| Life Extension | 12% | new | 1 year | FY 2024 · filed 4 Mar 2025 |
About this data
US-listed companies must disclose revenue from any single customer that reaches 10% of their total (ASC 280). ShadowGraph reads these disclosures from the XBRL data of every 10-K and 20-F we scan, keeps one value per fiscal year (restatements replace earlier values) and links each number to its filing. Companies that describe a customer only as "Customer A" are not listed by name. Figures are as reported; nothing here is investment advice.
All companies · Latest dependency shifts · Bulk data and API